Financial Performance - The company's revenue for Q1 2023 was CNY 13,601,286.14, representing a year-on-year decrease of 55.17% due to macroeconomic factors and delayed product deliveries[5]. - The net loss attributable to shareholders was CNY 10,405,956.98, with a basic and diluted earnings per share of -0.14 CNY[5]. - Total revenue for Q1 2023 was ¥13,601,286.14, a decrease of 55.2% compared to ¥30,343,000.90 in Q1 2022[20]. - Net loss for Q1 2023 was ¥11,084,835.28, compared to a net loss of ¥2,928,778.02 in Q1 2022, indicating a significant increase in losses[21]. - The total operating profit for Q1 2023 was -¥13,353,156.34, worsening from -¥3,839,466.61 in Q1 2022[20]. Research and Development - Research and development expenses totaled CNY 12,143,453.46, accounting for 89.28% of revenue, an increase of 61.03 percentage points compared to the previous year[6]. - Research and development expenses rose to ¥12,143,453.46 in Q1 2023, up 41.5% from ¥8,573,894.32 in Q1 2022[20]. - The company is focusing on enhancing its product development and market expansion strategies, although specific new products or technologies were not detailed in the report[19]. Cash Flow and Assets - The net cash flow from operating activities was -CNY 31,475,641.18, reflecting improved cash management despite the net loss[5][10]. - Cash flow from operating activities showed a net outflow of ¥31,475,641.18 in Q1 2023, compared to a net outflow of ¥186,145,033.03 in Q1 2022[23]. - Cash and cash equivalents as of March 31, 2023, were RMB 636,573,319.45, down from RMB 1,377,098,910.47, a decrease of about 53.8%[15]. - Cash and cash equivalents at the end of Q1 2023 were ¥633,129,375.45, down from ¥1,373,654,966.47 at the beginning of the period[24]. - Total cash inflow from investment activities in Q1 2023 was ¥1,182,192,301.53, while cash outflow was ¥1,884,357,304.07, resulting in a net cash outflow of ¥702,165,002.54[24]. Shareholder Information - The company reported a total of 3,705 common shareholders at the end of the reporting period[12]. - The top three shareholders held a combined 51.30% of the company's shares, indicating concentrated ownership[13]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,913,003,870.99, a decrease of 4.00% from the previous year[6]. - The company's total liabilities decreased to RMB 235,706,091.76 from RMB 304,975,688.57, representing a reduction of about 22.7%[17]. - The total equity attributable to shareholders decreased to RMB 1,684,102,059.28 from RMB 1,693,938,016.26, indicating a decline of approximately 0.9%[17]. - The company's accounts receivable decreased to RMB 130,410,141.32 from RMB 168,985,043.29, a decline of approximately 22.8%[15]. - Inventory increased to RMB 155,038,430.26 from RMB 145,923,692.14, reflecting an increase of about 6.5%[15]. - The company reported a significant increase in trading financial assets, rising to RMB 713,948,506.32 from RMB 21,838,766.40, a substantial increase of approximately 3,272.5%[15]. - The company has maintained its capital reserve at RMB 1,521,692,745.62, unchanged from the previous period[17]. Future Outlook - The company plans to continue focusing on R&D and maintaining a stable order backlog to support future growth[6]. - The company had approximately CNY 133 million in unrecognized revenue from orders on hand as of the end of the reporting period, indicating stable business development[6]. - The company's short-term borrowings and other current liabilities were not specified, indicating a potential area for future financial strategy[17].
晶品特装(688084) - 2023 Q1 - 季度财报